| Code | 08141 | ||||||||||
| MA number | 44/0439/11-S | ||||||||||
| Product Form: | plc ifc 5x25 mg (liek.inj.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Pharmaand GmbH, Austria | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | brown glass container | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 27.06.2011 |
| SPC: |
SPC_Levact 2,5 mg_ml_09.2023.pdf
|
| PIL: |
PIL_Levact 2,5 mg_ml_10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 18.08.2022 |
